A Comprehensive Revision of Radiation Immunotherapy and the Abscopal Effect in Central Nervous System Metastases: Reassessing the Frontier

Seventy years ago, Robin Mole introduced the concept of the abscopal effect to describe a rare phenomenon. This occurs when local radiation triggers an immune-mediated reduction in tumors outside the treated area but within the same organism. Observing this effect has been linked to improved overall and progression-free survival in patients who experience it. While the abscopal effect was once considered rare, it is now being observed more frequently due to the combination of radiation with immunotherapy. As a result, more researchers are exploring this study area, which shows promise for excellent results. This review focuses explicitly on the immunological implications of activating the abscopal effect through ionizing radiation in the central nervous system and explores the potentially involved immunological pathways.

References

Kang J, Demaria S, Formenti S . Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer. 2016; 4:51. PMC: 5028964. DOI: 10.1186/s40425-016-0156-7. View

Antonia S, Villegas A, Daniel D, Vicente D, Murakami S, Hui R . Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N Engl J Med. 2017; 377(20):1919-1929. DOI: 10.1056/NEJMoa1709937. View

Wang R, Zhou T, Liu W, Zuo L . Molecular mechanism of bystander effects and related abscopal/cohort effects in cancer therapy. Oncotarget. 2018; 9(26):18637-18647. PMC: 5915099. DOI: 10.18632/oncotarget.24746. View

Kiess A, Wolchok J, Barker C, Postow M, Tabar V, Huse J . Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment. Int J Radiat Oncol Biol Phys. 2015; 92(2):368-75. PMC: 4955924. DOI: 10.1016/j.ijrobp.2015.01.004. View

Reynders K, Illidge T, Siva S, Chang J, De Ruysscher D . The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev. 2015; 41(6):503-10. PMC: 4816218. DOI: 10.1016/j.ctrv.2015.03.011. View

Aldakhil S, Mathieu D . Abscopal effect leading to complete disappearance of extensive meningiomatosis after gamma knife radiosurgery: Case report. Front Surg. 2022; 9:908645. PMC: 9329627. DOI: 10.3389/fsurg.2022.908645. View

Mole R . Whole body irradiation; radiobiology or medicine?. Br J Radiol. 1953; 26(305):234-41. DOI: 10.1259/0007-1285-26-305-234. View

Filippi A, Fava P, Badellino S, Astrua C, Ricardi U, Quaglino P . Radiotherapy and immune checkpoints inhibitors for advanced melanoma. Radiother Oncol. 2016; 120(1):1-12. DOI: 10.1016/j.radonc.2016.06.003. View

Hiniker S, Reddy S, Maecker H, Subrahmanyam P, Rosenberg-Hasson Y, Swetter S . A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma. Int J Radiat Oncol Biol Phys. 2016; 96(3):578-88. PMC: 5077166. DOI: 10.1016/j.ijrobp.2016.07.005. View

10.

Goldberg S, Schalper K, Gettinger S, Mahajan A, Herbst R, Chiang A . Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial. Lancet Oncol. 2020; 21(5):655-663. PMC: 7380514. DOI: 10.1016/S1470-2045(20)30111-X. View

11.

Dewan M, Galloway A, Kawashima N, Dewyngaert J, Babb J, Formenti S . Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res. 2009; 15(17):5379-88. PMC: 2746048. DOI: 10.1158/1078-0432.CCR-09-0265. View

12.

Sahgal A, Aoyama H, Kocher M, Neupane B, Collette S, Tago M . Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2015; 91(4):710-7. DOI: 10.1016/j.ijrobp.2014.10.024. View

13.

Qin R, Olson A, Singh B, Thomas S, Wolf S, Bhavsar N . Safety and Efficacy of Radiation Therapy in Advanced Melanoma Patients Treated With Ipilimumab. Int J Radiat Oncol Biol Phys. 2016; 96(1):72-7. DOI: 10.1016/j.ijrobp.2016.04.017. View

14.

Long G, Trefzer U, Davies M, Kefford R, Ascierto P, Chapman P . Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial. Lancet Oncol. 2012; 13(11):1087-95. DOI: 10.1016/S1470-2045(12)70431-X. View

15.

Bardia A, Hurvitz S, Tolaney S, Loirat D, Punie K, Oliveira M . Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer. N Engl J Med. 2021; 384(16):1529-1541. DOI: 10.1056/NEJMoa2028485. View

16.

Escriva-de-Romani S, Arumi M, Bellet M, Saura C . HER2-positive breast cancer: Current and new therapeutic strategies. Breast. 2018; 39:80-88. DOI: 10.1016/j.breast.2018.03.006. View

17.

Pfannenstiel L, McNeilly C, Xiang C, Kang K, Diaz-Montero C, Yu J . Combination PD-1 blockade and irradiation of brain metastasis induces an effective abscopal effect in melanoma. Oncoimmunology. 2018; 8(1):e1507669. PMC: 6287893. DOI: 10.1080/2162402X.2018.1507669. View

18.

Ngwa W, Irabor O, Schoenfeld J, Hesser J, Demaria S, Formenti S . Using immunotherapy to boost the abscopal effect. Nat Rev Cancer. 2018; 18(5):313-322. PMC: 5912991. DOI: 10.1038/nrc.2018.6. View

19.

Trommer M, Yeo S, Persigehl T, Bunck A, Grull H, Schlaak M . Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition. Front Pharmacol. 2019; 10:511. PMC: 6530339. DOI: 10.3389/fphar.2019.00511. View

20.

Schouten L, Rutten J, Huveneers H, Twijnstra A . Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002; 94(10):2698-705. DOI: 10.1002/cncr.10541. View